In endocrine organ diseases, aberrant metabolism, function and survival of pancreatic β cells for example, as well as the development of glucose intolerance, hyperglycemia, and diabetes all involve pathogenic complications of the eIF2α phosphorylation pathway [128,129,130,131,132]. Here, EIF2A is linked to Glucose intolerance.